Product Information
JTE-907 is a cannabinoid drug that binds to the CB2 receptor and has been shown to have anti-inflammatory properties in animal models of inflammatory bowel disease. It also has a high affinity for the CB2 receptor, which is expressed in immune cells, and low affinity for the CB1 receptor. JTE-907 has been shown to decrease levels of pro-inflammatory cytokines and increase levels of anti-inflammatory cytokines. The drug also increases angiogenic factors, such as vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF), which are important for blood vessel formation. In addition, JTE-907 has been shown to inhibit neuronal activity in vitro and show beneficial effects on biological properties in animals with autoimmune diseases.
Chemical properties
Technical inquiry about: 3D-CJ175161 JTE-907
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
